| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Republic of Korea | 4 | |
| #2 | Australia | 2 | |
| #3 | Brazil | 2 | |
| #4 | Canada | 2 | |
| #5 | Japan | 2 | |
| #6 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Fang Jianmin | 11 |
| #2 | Li Dong | 8 |
| #3 | Dong Li | 3 |
| #4 | Jianmin Fang | 2 |
| #5 | Liu Zheng | 1 |
| #6 | Zheng Liu | 1 |
| Publication | Filing date | Title |
|---|---|---|
| JP2016106127A | FGFR-Fc FUSION PROTEIN AND USE THEREOF | |
| CA2834584A1 | Fgfr-fc fusion protein and use thereof | |
| KR20160011240A | Fusion protein for antagonizing angiogenesis inducible factors and uses thereof | |
| EP2161287A1 | OPTIMIZED TACI-Fc FUSION PROTEINS |